/*
    Thyroid Cancer Recurrence Dataset

    This dataset focuses on thyroid cancer recurrence after Radioactive Iodine (RAI) therapy.
    It contains 383 patient records with 13 key attributes, including age, gender,
    cancer staging, pathology type, risk classification, treatment response, and recurrence status.
    The data is valuable for predicting cancer recurrence, understanding risk factors,
    and evaluating treatment outcomes.

    ðŸ“Š Dataset Overview
    ðŸ“Œ Total Rows: 383
    ðŸ“Œ Total Columns: 13
    ðŸ“Œ No Missing Values

    ðŸ”¹ Column Descriptions
    Age : Age of the patient (in years).
    Gender : Patient's gender (Male or Female).
    Hx Radiotherapy : History of prior radiotherapy (Yes or No).
    Adenopathy : Presence of lymph node involvement (Yes or No).
    Pathology : Type of thyroid cancer (e.g., Micropapillary).
    Focality : Tumor focality (Uni-Focal or Multi-Focal).
    Risk : Cancer risk classification (Low, Intermediate, High).
    T : Tumor classification (T1, T2, etc.).
    N : Lymph node classification (N0, N1, etc.).
    M : Metastasis classification (M0, M1, etc.).
    Stage : Cancer staging (Stage I, II, III, IV).
    Response : Treatment response (Excellent, Indeterminate, etc.).
    Recurred : Whether cancer recurred (Yes or No).
*/